Jones Trading reiterated a Buy rating on ORIC Pharmaceuticals stock with a price target of $17.00, as shares traded at $11.23. The stock has shown remarkable momentum, gaining over 20% in the past ...
The president plans to sign an executive order that says the use of the Foreign Corrupt Practices Act has hurt American competitiveness.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback